Skip to main content
Clinical Trials/CTRI/2024/05/068049
CTRI/2024/05/068049
Not yet recruiting
Phase 4

Comparison of efficacy , safety and cost effectiveness of Amlodipine versusS-Amlodipine in patients with Grade I and grade II hypertension- aprospective, Randomised controlled trial , 16-weeks Double Blind study. - NI

Indira Gandhi Government Medical College and Hospital, Nagpur.0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Indira Gandhi Government Medical College and Hospital, Nagpur.
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Indira Gandhi Government Medical College and Hospital, Nagpur.

Eligibility Criteria

Inclusion Criteria

  • 1\. Male and female patients aged 18 to 75 years
  • 2\. Diagnosed with grade I \& II hypertension ( Systolic BP between 140\-179 mmHg and/or Diastolic BP between 90\-109 mmHg).
  • 3\. Patients who are able to comply with the study protocol ,attend scheduled visits ,willingness to participate in the study and provide informed consent.
  • 4\. OutPatient Department

Exclusion Criteria

  • 1\.Previous History of myocardial infarction , PTCA , CABG, angina pectoris or cerebrovascular accidents in the last 6 months .
  • 2\.History of secondary or malignant hypertension
  • 3\.History of congestive cardiac failure , cardiac arrhythmias, any other abnormalities in ECG.
  • 4\.Patient with known significant respiratory conditions .
  • 5\. Patient with known significant Neurological diseases , Coagulation disorders , metabolic or endocrine disorder (except Type 2 Diabetes Mellitus)
  • 6\. Uncontrolled Diabetes Mellitus (fasting blood glucose more than 140 mg/dl ) or diabetic edema or Type 2 Diabetes Mellitus taking insulin or oral hypoglycemic drugs other than Metformin or sulfonylureas and more than one sulfonylureas.
  • 7\. Patient with Liver or Kidney disorder
  • 8\. Patients who may develop edema feet by concomitant drug at screening :
  • a. Drugs that constrict intra renal blood vessels (eg. NSAIDS , Cyclosporine etc.)
  • b. Drugs that dilate arterioles (eg .vasodilators etc)

Outcomes

Primary Outcomes

Not specified

Similar Trials